Atara Biotherapeutics ATRA
NASDAQ ATRA
$9.48 +1.02 (+12.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Other Accumulated Expenses (2013 - 2026)

Updated

Atara Biotherapeutics (ATRA) reported Other Accumulated Expenses of $3.46 million for Q2 2026, down 54.9% from $7.67 million a year earlier but up 17.7% from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) Other Accumulated Expenses (2013 - 2026) Analysis & Trends

At the end of FY2025, Atara Biotherapeutics posted Other Accumulated Expenses of $2.98 million, down 85.2% from FY2024.

  • Other Accumulated Expenses has a five-year compound annual growth rate of -28.4% (FY2020 to FY2025).
  • By year, Other Accumulated Expenses came in at $20.16 million in FY2024 (-36.7%), $31.83 million in FY2023 (+27.3%), $24.99 million in FY2022 (+85.8%) and $13.45 million in FY2021 (-14.9%).
  • Five-year quarterly Other Accumulated Expenses spans a low of $2.94 million in Q1 2026 and a high of $33.05 million in Q1 2024.
  • Year over year, Other Accumulated Expenses has now declined in each of the last eight quarters, with an average decline of 55.5% over the last eight quarters.
  • The high point for year-over-year Other Accumulated Expenses in five years was Q3 2022 (growth of 128.7%); the low point was Q1 2026 (a decline of 87.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.94 million (Q1 2026), $2.98 million (Q4 2025) and $4.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Atara Biotherapeutics 142.51 Mn 132.61 Mn 439,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.46 Mn
Mar 31, 2026 2.94 Mn
Dec 31, 2025 2.98 Mn
Sep 30, 2025 4.65 Mn
Jun 30, 2025 7.67 Mn
Mar 31, 2025 24.14 Mn
Dec 31, 2024 20.16 Mn
Sep 30, 2024 23.64 Mn
Jun 30, 2024 26.15 Mn
Mar 31, 2024 33.05 Mn
Dec 31, 2023 31.83 Mn
Sep 30, 2023 23.97 Mn
Jun 30, 2023 25.17 Mn
Mar 31, 2023 23.77 Mn
Dec 31, 2022 24.99 Mn
Sep 30, 2022 22.81 Mn
Jun 30, 2022 19.78 Mn
Mar 31, 2022 13.99 Mn
Dec 31, 2021 13.45 Mn
Sep 30, 2021 9.97 Mn
API Access

Atara Biotherapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ATRA&period=max&api_key=YOUR_API_KEY